Deerfield Management Company, L.P. (Series C) Ideaya Biosciences, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,267,551 shares of IDYA stock, worth $68.9 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
3,267,551
Previous 2,736,000
19.43%
Holding current value
$68.9 Million
Previous $70.3 Million
23.88%
% of portfolio
1.35%
Previous 1.74%
Shares
10 transactions
Others Institutions Holding IDYA
# of Institutions
212Shares Held
80.3MCall Options Held
80.3KPut Options Held
30.5K-
Black Rock Inc. New York, NY6.81MShares$144 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.4MShares$135 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.09MShares$107 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.77MShares$101 Million0.18% of portfolio
-
Logos Global Management LP San Francisco, CA3.5MShares$73.9 Million11.17% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.01B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...